Dexcom Inc. executives may have thought a $30 million beat of the consensus estimates for third quarter revenue and 20% growth year-over-year provided a treat to shareholders, but investors seemed to ...

After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...

DexCom may be a major player in the market for continuous glucose monitors, but that doesn’t means it’s shielded from ...

By Sneha S K (Reuters) -Dexcom shares tumbled 12.8% on Friday after executives signaled that the medical device maker's 2026 ...

The Russell Midcap® Growth Index (up 2.78%) underperformed the Russell Midcap® Value Index (up 6.16%), losing some momentum after a notably strong second quarter.

As people around the world seek ways to manage their diabetes, the continuous glucose monitor (CGM) market continues to grow ...

Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.

Scan, the smart-health device that analyzes your urine from inside your toilet bowl, is finally available to order globally.

Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q3 CY2025, with sales up 21.6% year on ...

A Senate hearing for President Donald Trump’s surgeon general pick, Dr. Casey Means, has been postponed because she went into labor.

Casey Means' Senate hearing has been postponed. The news comes just hours before the President Donald Trump's surgeon general ...

DexCom Inc. (NASDAQ: DXCM) is one of the best NASDAQ growth stocks to buy for the next 5 years. On October 15, Truist analyst ...